ArticleFrontiers in psychiatry2026
Diazepam combined with aripiprazole in the treatment of a catatonic stupor patient with venous thrombosis: a case report.
Article in Frontiers in psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Catatonic stupor is a potentially life-threatening condition, with key symptoms including mutism, immobility, refusal to eat, and negativism. It may be accompanied by complications such as infection, hyperthermia, and thrombosis. When patients develop concurrent severe physical illnesses, this is very likely to cause delays in diagnosis and treatment, further increasing the risk of clinical deterioration. Methods: This article reports a 52-year-old patient with schizophrenia presenting with catatonic stupor and failure to establish effective communication. The uniqueness of this case is that the patient was admitted with concurrent pulmonary infection, pulmonary embolism, and lower limb deep venous thrombosis, and modified electroconvulsive therapy (MECT) was associated with substantial clinical risks. The patient was eventually treated with a combination of diazepam and aripiprazole. During treatment, the severity of the patient's catatonic symptoms was assessed using the Bush-Francis Catatonia Rating Scale (BFCRS). Result: After combined treatment with diazepam and aripiprazole, the patient's catatonic symptoms were relieved, and various functions gradually recovered. The BFCRS score reduction rate exceeded 70%, indicating that the expected therapeutic effect was achieved. Conclusion: As a relatively safe and effective intervention regimen, the combination treatment of diazepam and aripiprazole may be applicable to high-risk catatonic patients with relative contraindications to MECT, such as those complicated with venous thrombosis, providing a new therapeutic option for catatonic stupor.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.